An observational study assessing the presence and level of IgG antibody response to the spike protein of SARS-CoV-2 generated by natural infection and following vaccination
Testing For All offers affordable and accessible testing, and enables an individual to access highly accurate laboratory based testing to better understand their unique health and risk status.
After an individual has tested with us we invite users to this observational study to provide further information. This provides context to the results, and lets an individual see if their immune response is typical. It is known that vaccines do fail for various reasons, including issues with manufacture, transport and storage; but also how the individual’s body responds
Participants will be required to answer a series of questions in an online form
By taking part you will contribute to one of the most advanced observational studies for quantitative IgG response, and hence better inform your own situation and the community of people that choose to test with Testing For All. It is also hoped that this body of data will further inform public policy
The risks of taking part are low as the primary risk is confidentiality related to sharing your data with Testing For All. Testing For All handles data in accordance with our Privacy Notice, however this observational study has specific risk that you should be aware of:
We use high quality systems to store and process your survey data, and the risk of a data breach that overcomes the data privacy techniques we use to protect your data is very low
Version No: TFA/PIS/AB/1.0